Peter Ljubenkov, MD

Title(s)Assistant Professor, Neurology
SchoolSchool of Medicine
Address675 Nelson Rising Lane, #192
San Francisco CA 94158
Phone--
ORCID ORCID Icon0000-0002-3348-9215 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    Lewis Katz School of MedicineMD2011
    UC San DiegoResidency2015Neurology
    UCSFFellowship2018Behavioral Neurology

    Collapse Overview 
    Collapse Overview
    Dr. Peter A. Ljubenkov is a behavioral neurologist who specializes in caring for patients experiencing memory, language and behavioral changes due to neurological conditions, such as Alzheimer's disease, Lewy body dementia and other causes of dementia. He has special expertise in diagnosing and treating frontotemporal dementia (a group of neurodegenerative diseases that affect the frontal and temporal lobes) and related conditions, including progressive supranuclear palsy and corticobasal degeneration. Ljubenkov also serves as the associate fellowship director of the UCSF Memory and Aging Center's Behavioral Neurology Training Program fellowship, which trains doctors for careers in research and clinical care involving patients with dementia.

    In research, Ljubenkov is active in clinical therapeutic trials, studies enrolling human participants to explore new potential treatments for patients with dementia.

    Ljubenkov earned his medical degree at Lewis Katz School of Medicine at Temple University. He completed a residency in neurology at the University of California, San Diego, followed by a fellowship in behavioral neurology at UCSF.

    Collapse Research 
    Collapse Research Activities and Funding
    Veri-T: A phase 1 Placebo-Controlled Trial of Verdiperstat in Semantic Variant Primary Progressive Aphasia Due to Underlying FTLD-TDP
    NIH R01AG073482Aug 1, 2021 - Jul 31, 2026
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy. Ann Neurol. 2024 Apr 05. Garcia-Cordero I, Anastassiadis C, Khoja A, Morales-Rivero A, Thapa S, Vasilevskaya A, Davenport C, Sumra V, Couto B, Multani N, Taghdiri F, Anor C, Misquitta K, Vandevrede L, Heuer H, Tang-Wai D, Dickerson B, Pantelyat A, Litvan I, Boeve B, Rojas JC, Ljubenkov P, Huey E, Fox S, Kovacs GG, Boxer A, Lang A, Tartaglia MC, 4-R-Tauopathy Neuroimaging Initiative Consortium, and the Alzheimer's Disease Neuroimaging Initiativ. PMID: 38578117.
      View in: PubMed   Mentions:    Fields:    
    2. Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement. 2024 Mar 27. Samudra N, Fischer DL, Lenio S, Lario Lago A, Ljubenkov PA, Rojas JC, Seeley WW, Spina S, Staffaroni AM, Tablante J, Wekselman F, Lamoureux J, Concha-Marambio L, Grinberg LT, Boxer AL, VandeVrede L. PMID: 38539061.
      View in: PubMed   Mentions:    Fields:    
    3. Validation of Cerebrospinal Fluid Alpha-synuclein Assay against Autopsy in Non-Parkinson’s Disease Neurodegenerative Syndromes. Alzheimer's & Dementia. 2023 Dec 25; 19(S15). Samudra SN, Ljubenkov LP, Rojas RJ, Staffaroni SA, Wekselman WF, Jennifer JL, Grinberg GL, Boxer BA, VandeVrede VL. .
      View in: Publisher Site   Mentions:
    4. Clinical value of CSF TMEM106B in familial and sporadic frontotemporal lobar degeneration. Alzheimer's & Dementia. 2023 Dec 25; 19(S15). Rojas RJ, Cobigo CY, Wise WA, Li LJ, Loureiro LJ, Worringer WK, Heuer HH, Ljubenkov LP, VandeVrede VL, Staffaroni SA, Lago LA, Ramos RE, Prudencio PM, Marks MJ, Cook CC, Pernieel PJ, Rademakers RR, Petrucelli PL, Boeve BB, Rosen RH, Boxer BA, ALLFTD A. .
      View in: Publisher Site   Mentions:
    5. [18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. J Nucl Med. 2023 12 01; 64(12):1980-1989. Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, Rosen HJ, Litvan I, Grossman M, Boeve B, Pantelyat A, Tartaglia MC, Irwin DJ, Dickerson BC, Baker SL, Boxer AL, Rabinovici GD, La Joie R. PMID: 37918868; PMCID: PMC10690126.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab. Acta Neuropathol. 2023 11; 146(5):777-781. VandeVrede L, La Joie R, Horiki S, Mundada NS, Koestler M, Hwang JH, Ljubenkov PA, Rojas JC, Rabinovici GD, Boxer AL, Seeley WW. PMID: 37725166; PMCID: PMC10564667.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Silencing tau to treat early Alzheimer's disease. Nat Med. 2023 Jun; 29(6):1320-1321. Ljubenkov PA, Rabinovici GD. PMID: 37198457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome. JAMA Neurol. 2023 05 01; 80(5):495-505. VandeVrede L, La Joie R, Thijssen EH, Asken BM, Vento SA, Tsuei T, Baker SL, Cobigo Y, Fonseca C, Heuer HW, Kramer JH, Ljubenkov PA, Rabinovici GD, Rojas JC, Rosen HJ, Staffaroni AM, Boeve BF, Dickerson BC, Grossman M, Huey ED, Irwin DJ, Litvan I, Pantelyat AY, Tartaglia MC, Dage JL, Boxer AL. PMID: 37010841; PMCID: PMC10071401.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):541-549. Asken BM, Ljubenkov PA, Staffaroni AM, Casaletto KB, Vandevrede L, Cobigo Y, Rojas-Rodriguez JC, Rankin KP, Kornak J, Heuer H, Shigenaga J, Appleby BS, Bozoki AC, Domoto-Reilly K, Ghoshal N, Huey E, Litvan I, Masdeu JC, Mendez MF, Pascual B, Pressman P, Tartaglia MC, Kremers W, Forsberg LK, Boeve BF, Boxer AL, Rosen HJ, Kramer JH, ALLFTD Consortium Investigators. PMID: 36977552; PMCID: PMC10313977.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. [18F]PI-2620 PET in four-repeat tauopathies: a preliminary study. Alzheimer's & Dementia. 2022 Dec 20; 18(S6). Soleimani-Meigooni SD, Thomas TW, Brendel BM, Vento VS, Heuer HH, Ljubenkov LP, Rojas RJ, Chen CM, Iaccarino IL, La Joie LR, Mundada MN, Boeve BB, Grossman GM, Dickerson DB, Irwin ID, Litvan LI, Pantelyat PA, Tartaglia TC, Rabinovici RG, Baker BS, Boxer BA. .
      View in: Publisher Site   Mentions:
    11. Introduction to Veri-T: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD-TDP. Alzheimer's & Dementia. 2022 Dec 20; 18(S10). Ljubenkov LP, Staffaroni SA, Rojas RJ, VandeVrede VL, Koestler KM, Sulse ST, Moreton MJ, Horiki HS, Heuer HH, Grant GI, Irwin ID, Boeve BB, Rosen RH, Knopman KD, Bowser BR, Grossman GM, Qureshi QI, Boxer BA. .
      View in: Publisher Site   Mentions:
    12. Autopsy Results from the ENGAGE Trial of Aducanumab: Lessons from Co-pathology. Alzheimer's & Dementia. 2022 Dec 20; 18(S10). Horiki HS, VandeVrede VL, La Joie LR, Ljubenkov LP, Koestler KM, Rojas RJ, Rabinovici RG, Boxer BA, Seeley SW. .
      View in: Publisher Site   Mentions:
    13. The Neurofilament Surveillance Project (NSP): A biomarker study to sample blood quarterly in familial frontotemporal lobar degeneration. Alzheimer's & Dementia. 2022 Dec 20; 18(S5). Acuna-Narvaez AR, Heuer HH, Forsberg FL, Alward AA, Graham GD, Fishman FA, Nelson NK, Kolander KT, Fillit FH, Galpern GW, Hung HS, Mason MC, Mignon ML, Ni NY, Simen SA, Tesseur TI, Tsai TR, Yeh YF, Mester MC, Ljubenkov LP, Rosen RH, Boeve BB, Boxer BA, Pearlman PR, Mitic ML, Investigators IN. .
      View in: Publisher Site   Mentions:
    14. Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat Med. 2022 10; 28(10):2194-2206. Staffaroni AM, Quintana M, Wendelberger B, Heuer HW, Russell LL, Cobigo Y, Wolf A, Goh SM, Petrucelli L, Gendron TF, Heller C, Clark AL, Taylor JC, Wise A, Ong E, Forsberg L, Brushaber D, Rojas JC, VandeVrede L, Ljubenkov P, Kramer J, Casaletto KB, Appleby B, Bordelon Y, Botha H, Dickerson BC, Domoto-Reilly K, Fields JA, Foroud T, Gavrilova R, Geschwind D, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grossman M, Hall MGH, Hsiung GY, Huey ED, Irwin D, Jones DT, Kantarci K, Kaufer D, Knopman D, Kremers W, Lago AL, Lapid MI, Litvan I, Lucente D, Mackenzie IR, Mendez MF, Mester C, Miller BL, Onyike CU, Rademakers R, Ramanan VK, Ramos EM, Rao M, Rascovsky K, Rankin KP, Roberson ED, Savica R, Tartaglia MC, Weintraub S, Wong B, Cash DM, Bouzigues A, Swift IJ, Peakman G, Bocchetta M, Todd EG, Convery RS, Rowe JB, Borroni B, Galimberti D, Tiraboschi P, Masellis M, Finger E, van Swieten JC, Seelaar H, Jiskoot LC, Sorbi S, Butler CR, Graff C, Gerhard A, Langheinrich T, Laforce R, Sanchez-Valle R, de Mendonça A, Moreno F, Synofzik M, Vandenberghe R, Ducharme S, Le Ber I, Levin J, Danek A, Otto M, Pasquier F, Santana I, Kornak J, Boeve BF, Rosen HJ, Rohrer JD, Boxer AL, Frontotemporal Dementia Prevention Initiative (FPI) Investigators. PMID: 36138153; PMCID: PMC9951811.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    15. Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia. Neurology. 2022 Aug 01; 99(5):e488-e499. Toller G, Cobigo Y, Ljubenkov PA, Appleby BS, Dickerson BC, Domoto-Reilly K, Fong JC, Forsberg LK, Gavrilova RH, Ghoshal N, Heuer HW, Knopman DS, Kornak J, Lapid MI, Litvan I, Lucente DE, Mackenzie IR, McGinnis SM, Miller BL, Pedraza O, Rojas JC, Staffaroni AM, Wong B, Wszolek ZK, Boeve BF, Boxer AL, Rosen HJ, Rankin KP, and the ALLFTD research consortium. PMID: 35584922; PMCID: PMC9421596.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Case Report: Novel CSF1R Variant in a Patient With Behavioral Variant Frontotemporal Dementia Syndrome With Prodromal Repetitive Scratching Behavior. Front Neurol. 2022; 13:909944. Friedberg A, Ramos EM, Yang Z, Bonham LW, Yokoyama JS, Ljubenkov PA, Younes K, Geschwind DH, Miller BL. PMID: 35812083; PMCID: PMC9256970.
      View in: PubMed   Mentions:
    17. Clinical Trial Development in Frontotemporal Lobar Degeneration. . 2022 Mar 3; 216-231. Ljubenkov LP, Boxer BA. .
      View in: Publisher Site   Mentions:
    18. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration. Neurology. 2022 03 15; 98(11):e1137-e1150. Mattsson-Carlgren N, Grinberg LT, Boxer A, Ossenkoppele R, Jonsson M, Seeley W, Ehrenberg A, Spina S, Janelidze S, Rojas-Martinex J, Rosen H, La Joie R, Lesman-Segev O, Iaccarino L, Kollmorgen G, Ljubenkov P, Eichenlaub U, Gorno-Tempini ML, Miller B, Hansson O, Rabinovici GD. PMID: 35173015; PMCID: PMC8935438.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    19. A phase 1b, randomized, double-blind, placebo-controlled, parallel cohort safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy study of intravenously infused BIIB092 in patients with four different primary tauopathy syndromes. Alzheimer's & Dementia. 2021 Dec 31; 17(S9). Ljubenkov LP, Vandevrede VL, Rojas RJ, Tsai TR, Koestler KM, Graham GD, Dam DT, Boxer BA. .
      View in: Publisher Site   Mentions:
    20. Clinical value of CSF tau, p-tau181, neurogranin and neurofilaments in familial frontotemporal lobar degeneration. Alzheimer's & Dementia. 2021 Dec 1; 17(S4). Rojas RJ, Heuer HH, Chen CW, Czerkowicz CJ, Graham GD, Forsberg FL, Brushaber BD, Appleby AB, Ramos RE, Coppolla CG, Bordelon BY, Botha BH, Dickerson DB, Dickson DD, Domoto-Reilly DK, Fagan FA, Fields FJ, Fong FJ, Foroud FT, Galasko GD, Gavrilova GR, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GN, Graff-Radford GJ, Grant GI, Grossman GM, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Knopman KD, Kornak KJ, Kremers KW, Lapid LM, Leger LG, Litvan LI, Ljubenkov LP, Lucente LD, Mackenzie MI, Masdeu MJ, McMillan MC, Mendez MM, Miller MB, Miyagawa MT, Onyike OC, Pascual PB, Pedraza PO, Petrucelli PL, Rademakers RR, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, Savica SR, Seeley SW, Staffaroni SA, Tartaglia TM, Toga TA, Weintraub WS, Wong WB, Wszolek WZ, Vandevrede VL, Boeve BB, Rosen RH, Boxer BA. .
      View in: Publisher Site   Mentions:
    21. Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood. Alzheimer's & Dementia. 2021 Dec 1; 17(S7). Bajorek BL, Kiekhofer KR, Hall HM, Taylor TJ, Lucente LD, Brushaber BD, Appleby AB, Coppolla CG, Bordelon BY, Botha BH, Dickerson DB, Dickson DD, Domoto-Reilly DK, Fagan FA, Fields FJ, Fong FJ, Foroud FT, Forsberg FL, Galasko GD, Gavrilova GR, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GN, Graff-Radford GJ, Grant GI, Grossman GM, Heuer HH, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Kornak KJ, Kremers KW, Lapid LM, Leger LG, Litvan LI, Ljubenkov LP, Mackenzie MI, Masdeu MJ, McMillan MC, Mendez MM, Miller MB, Miyagawa MT, Onyike OC, Pascual PB, Pedraza PO, Petrucelli PL, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, Savica SR, Rojas RJ, Seeley SW, Tartaglia TM, Toga TA, Weintraub WS, Wong WB, Wszolek WZ, Vandevrede VL, Boeve BB, Boxer BA, Rosen RH, Staffaroni SA, Consortium CA. .
      View in: Publisher Site   Mentions:
    22. Gearing up for the future: Exploring facilitators and barriers to inform clinical trial design in frontotemporal lobar degeneration. Alzheimer's & Dementia. 2021 Dec 1; 17(S7). Banga BY, Lai LY, Kim KP, Boeve BB, Boxer BA, Rosen RH, Forsberg FL, Heuer HH, Brushaber BD, Appleby AB, Biernacka BJ, Bordelon BY, Botha BH, Bozoki BA, Brannelly BP, Dickerson DB, Dickinson DS, Dickson DD, Domoto-Reilly DK, Faber FK, Fagan FA, Fields FJ, Fishman FA, Foroud FT, Galasko GD, Gavrilova GR, Gendron GT, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grant GI, Grossman GM, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Karydas KA, Kaufer KD, Knopman KD, Kramer KJ, Kremers KW, Kornak KJ, Kukull KW, Lagone LE, Leger LG, Litvan LI, Ljubenkov LP, Lucente LD, Mackenzie MI, Manoochehri MM, Masdeu MJ, McGinnis MS, Mendez MM, Miller MB, Miyagawa MT, Nelson NK, Onyike OC, Pantelyat PA, Pascual PB, Pearlman PR, Petrucelli PL, Pottier PC, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, Rojas RJ, Sabbagh SM, Salmon SD, Savica SR, Seeley SW, Staffaroni SA, Syrjanen SJ, Tartaglia TM, Tatton TN, Taylor TJ, Toga TA, Weintraub WS, Wheaton WD, Wong WB, Wszolek WZ, Consortium CA. .
      View in: Publisher Site   Mentions:
    23. Diagnostic value of plasma P-tau217 in frontotemporal dementia spectrum disorders. Alzheimer's & Dementia. 2021 Dec 1; 17(S4). Rojas RJ, Vandevrede VL, Heuer HH, Toller TG, Thijssen TE, Proctor PN, Forsberg FL, Brushaber BD, Ramos RE, Coppola CG, Appleby AB, Bordelon BY, Botha BH, Dickerson DB, Dickson DD, Domoto-Reilly DK, Fagan FA, Fields FJ, Fong FJ, Foroud FT, Galasko GD, Gavrilova GR, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GN, Graff-Radford GJ, Grant GI, Grossman GM, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Knopman KD, Kornak KJ, Kremers KW, Lapid LM, Leger LG, Litvan LI, Ljubenkov LP, Lucente LD, Mackenzie MI, Masdeu MJ, McMillan MC, Mendez MM, Miller MB, Miyagawa MT, Onyike OC, Pascual PB, Pedraza PO, Petrucelli PL, Rademakers RR, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, Savica SR, Seeley SW, Staffaroni SA, Trataglia TM, Toga TA, Weintraub WS, Wong WB, Wszolek WZ, Dage DJ, Boeve BB, Rosen RH, Boxer BA. .
      View in: Publisher Site   Mentions:
    24. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. JAMA Netw Open. 2021 09 01; 4(9):e2125584. Ljubenkov PA, Edwards L, Iaccarino L, La Joie R, Rojas JC, Koestler M, Harris B, Boeve BF, Borroni B, van Swieten JC, Grossman M, Pasquier F, Frisoni GB, Mummery CJ, Vandenberghe R, Le Ber I, Hannequin D, McGinnis SM, Auriacombe S, Onofrj M, Goodman IJ, Riordan HJ, Wisniewski G, Hesterman J, Marek K, Haynes BA, Patzke H, Koenig G, Hilt D, Moebius H, Boxer AL. PMID: 34559230; PMCID: PMC8463943.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. Front Neurol. 2021; 12:694872. Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. PMID: 34276544; PMCID: PMC8284317.
      View in: PubMed   Mentions: 10  
    26. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration. Neurology. 2021 05 04; 96(18):e2296-e2312. Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA, Heuer HW, Fong JC, Taylor JB, Veras E, Song L, Jeromin A, Hanlon D, Yu L, Khinikar A, Sivasankaran R, Kieloch A, Valentin MA, Karydas AM, Mitic LL, Pearlman R, Kornak J, Kramer JH, Miller BL, Kantarci K, Knopman DS, Graff-Radford N, Petrucelli L, Rademakers R, Irwin DJ, Grossman M, Ramos EM, Coppola G, Mendez MF, Bordelon Y, Dickerson BC, Ghoshal N, Huey ED, Mackenzie IR, Appleby BS, Domoto-Reilly K, Hsiung GR, Toga AW, Weintraub S, Kaufer DI, Kerwin D, Litvan I, Onyike CU, Pantelyat A, Roberson ED, Tartaglia MC, Foroud T, Chen W, Czerkowicz J, Graham DL, van Swieten JC, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Finger E, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler CR, Gerhard A, Levin J, Danek A, Otto M, Sorbi S, Cash DM, Convery RS, Bocchetta M, Foiani M, Greaves CV, Peakman G, Russell L, Swift I, Todd E, Rohrer JD, Boeve BF, Rosen HJ, Boxer AL, ALLFTD and GENFI consortia. PMID: 33827960; PMCID: PMC8166434.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    27. FTLD Treatment: Current Practice and Future Possibilities. Adv Exp Med Biol. 2021; 1281:297-310. Ljubenkov PA, Boxer AL. PMID: 33433882.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol. Alzheimer's & Dementia. 2020 Dec 7; 16(S6). Boeve BB, Boxer BA, Rosen RH, Forsberg FL, Heuer HH, Brushaber BD, Appleby AB, Biernacka BJ, Bordelon BY, Botha BH, Brannelly BP, Dickerson DB, Dickson DD, Kimiko KD, Faber FK, Fagan FA, Fields FJ, Fishman FA, Foroud FT, Galasko GD, Gavrilova GR, Gendron GT, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grant GI, Grossman GM, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Karydas KA, Kaufer KD, Knopman KD, Kramer KJ, Kremers KW, Kornak KJ, Kukull KW, Lagone LE, Leger LG, Litvan LI, Ljubenkov LP, Lucente LD, Mackenzie MI, Manoochehri MM, Masdeu MJ, McGinnis MS, Mendez MM, Miller MB, Miyagawa MT, Nelson NK, Onyike OC, Pantelyat PA, Pascual PB, Pearlman PR, Petrucelli PL, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, Rojas RJ, Sabbagh SM, Salmon SD, Savica SR, Seeley SW, Staffaroni SA, Syrjanen SJ, Tartaglia TC, Tatton TN, Taylor TJ, Toga TA, Weintraub WS, Wheaton WD, Wong WB, Wszolek WZ. .
      View in: Publisher Site   Mentions:
    29. Plasma biomarkers of inflammation reflect disease state in autosomal dominant forms of familial frontotemporal dementia. Alzheimer's & Dementia. 2020 Dec 7; 16(S5). Ljubenkov LP, Staffaroni SA, Casaletto CK, Rojas RJ, Vandevrede VL, Heuer HH, Elahi EF, Brushaber BD, Foroud FT, Forsberg FL, Karydas KA, Boeve BB, Rosen RH, Boxer BA, Kramer KJ, Investigators IA. .
      View in: Publisher Site   Mentions:
    30. Plasma neurofilament light chain levels reflect caregiver burden and social cognition measures in familial frontotemporal lobar degeneration (FTLD). Alzheimer's & Dementia. 2020 Dec 7; 16(S4). Heuer HH, Rojas RJ, Toller TG, Rankin RK, Brushaber BD, Appleby AB, Bordelon BY, Dickerson DB, Kimiko KD, Faber FK, Foroud FT, Forsberg FL, Ghoshal GN, Grant GI, Graff-Radford GN, Grossman GM, Hsiung HG, Huey HE, Karydas KA, Kaufer KD, Kerwin KD, Lagone LE, Litvan LI, Ljubenkov LP, Mackenzie MI, Mendez MM, Miller MB, Onyike OC, Ramos RE, Rascovsky RK, Roberson RE, Tartaglia TC, Weintraub WS, Boeve BB, Rosen RH, Boxer BA, Investigators IA. .
      View in: Publisher Site   Mentions:
    31. Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD. Alzheimer's & Dementia. 2020 Dec 7; 16(S5). Vandevrede VL, Rojas RJ, Wang WP, Heuer HH, Karydas KA, Ljubenkov LP, Boeve BB, Rosen RH, Boxer BA, Investigators IA. .
      View in: Publisher Site   Mentions:
    32. Neuropsychiatric abnormalities in familial frontotemporal dementia: Findings from the LEFFTDS Cohort. Alzheimer's & Dementia. 2020 Dec 7; 16(S6). Forsberg FL, Boeve BB, Rosen RH, Boxer BA, Syrjanen SJ, Brushaber BD, Coppolla CG, Dickerson DB, Fields FJ, Fong FJ, Gavrilova GR, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grossman GM, Heuer HH, Hsiung HG, Huey HE, Irwin ID, Jones JD, Kantarci KK, Karydas KA, Knopman KD, Kornak KJ, Kramer KJ, Kremers KW, Kukull KW, Ljubenkov LP, Mackenzie MI, McGinnis MS, Miller MB, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Sturm SV, Staffaroni SA, Taylor TJ, Wong WB, Wszolek WZ. .
      View in: Publisher Site   Mentions:
    33. Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab. Alzheimers Dement (Amst). 2020; 12(1):e12101. VandeVrede L, Gibbs DM, Koestler M, La Joie R, Ljubenkov PA, Provost K, Soleimani-Meigooni D, Strom A, Tsoy E, Rabinovici GD, Boxer AL. PMID: 33072846; PMCID: PMC7545921.
      View in: PubMed   Mentions: 28  
    34. Four-Repeat Tauopathies: Current Management and Future Treatments. Neurotherapeutics. 2020 10; 17(4):1563-1581. VandeVrede L, Ljubenkov PA, Rojas JC, Welch AE, Boxer AL. PMID: 32676851; PMCID: PMC7851277.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    35. The ARTFL LEFFTDS Frontotemporal Lobar Degeneration (ALLFTD) Protocol: Preliminary Data and Future Plans (2081). Neurology. 2020 Apr 14; 94(15_supplement). Boeve BB, Boxer BA, Rosen RH, Forsberg FL, Heuer HH, Brushaber BD, Appleby AB, Biernacka BJ, Bordelon BY, Botha BH, Brannelly BP, Dickerson DB, Dickinson DS, Dickson DD, Domoto-Reilly DK, Faber FK, Fagan FA, Fields FJ, Fishman FA, Foroud FT, Galasko GD, Gavrilova GR, Gendron GT, Geschwind GD, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grant GI, Grossman GM, Hsiung HG, Huang HE, Huey HE, Irwin ID, Jones JD, Kantarci KK, Karydas KA, Kaufer KD, Knopman KD, Kramer KJ, Kremers KW, Kornak KJ, Kukull KW, Lagone LE, Litvan LI, Ljubenkov LP, Lucente LD, Mackenzie MI, Manoochehri MM, Masdeu MJ, McGinnis MS, Mendez MM, Miller MB, Miyagawa MT, Nelson NK, Onyike OC, Pantelyat PA, Pascual PB, Pearlman PR, Petrucelli PL, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Rexach RJ, Ritter RA, Roberson RE, -Martinez -J, Sabbagh SM, Salmon SD, Savica SR, Seeley SW, Staffaroni SA, Syrjanen SJ, Tartaglia TC, Tatton TN, Taylor TJ, Toga TA, Weintraub WS, Wheaton WD, Wong WB, Wszolek WZ. .
      View in: Publisher Site   Mentions:
    36. Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2020 May; 7(4):440-447. VandeVrede L, Dale ML, Fields S, Frank M, Hare E, Heuer HW, Keith K, Koestler M, Ljubenkov PA, McDermott D, Ohanesian N, Richards J, Rojas JC, Thijssen EH, Walsh C, Wang P, Wolf A, Quinn JF, Tsai R, Boxer AL. PMID: 32373661; PMCID: PMC7197321.
      View in: PubMed   Mentions: 23  
    37. Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia. JAMA Neurol. 2020 03 01; 77(3):358-366. Liu AJ, Staffaroni AM, Rojas-Martinez JC, Olney NT, Alquezar-Burillo C, Ljubenkov PA, La Joie R, Fong JC, Taylor J, Karydas A, Ramos EM, Coppola G, Boxer AL, Rabinovici GD, Miller BL, Kao AW. PMID: 31860018; PMCID: PMC6990672.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial. JAMA Neurol. 2020 02 01; 77(2):215-224. Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL. PMID: 31710340; PMCID: PMC6865783.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    39. Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):49-59. Olney NT, Ong E, Goh SM, Bajorek L, Dever R, Staffaroni AM, Cobigo Y, Bock M, Chiang K, Ljubenkov P, Kornak J, Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dickerson BC, Dickinson S, Domoto-Reilly K, Faber K, Ferrall J, Fields J, Fishman A, Fong J, Foroud T, Forsberg LK, Gearhart DJ, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford NR, Grant I, Grossman M, Haley D, Hsiung G, Huey ED, Irwin DJ, Jones DT, Kantarci K, Karydas AM, Kaufer D, Kerwin D, Knopman DS, Kramer JH, Kraft R, Kremers W, Kukull W, Lapid MI, Litvan I, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley EC, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wong B, Wszolek Z, Boxer AL, Boeve BF, Rosen HJ, ARTFL and LEFFTDS consortia. PMID: 31784375; PMCID: PMC6988137.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    40. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):37-48. Staffaroni AM, Cobigo Y, Goh SM, Kornak J, Bajorek L, Chiang K, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dever R, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Heuer HW, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kramer JH, Kremers WK, Kukull WA, Litvan I, Ljubenkov PA, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Rosen HJ, ARTFL/LEFFTDS consortium. PMID: 31272932; PMCID: PMC6938544.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    41. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimers Dement. 2020 01; 16(1):60-70. Heuer HW, Wang P, Rascovsky K, Wolf A, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber DE, Caso C, Coppola G, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Ferrall J, Fields J, Fishman A, Fong J, Foroud T, Forsberg LK, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey E, Irwin D, Jones D, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Kraft R, Kremers WK, Kukull W, Litvan I, Ljubenkov P, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Roberson ED, Rogalski E, Sengdy P, Shaw L, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski J, Weintraub S, Wong B, Wszolek Z, Boeve BF, Rosen HJ, Boxer AL, ARTFL and LEFFTDS consortia. PMID: 31914226; PMCID: PMC7192555.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020 01; 16(1):118-130. Ramos EM, Dokuru DR, Van Berlo V, Wojta K, Wang Q, Huang AY, Deverasetty S, Qin Y, van Blitterswijk M, Jackson J, Appleby B, Bordelon Y, Brannelly P, Brushaber DE, Dickerson B, Dickinson S, Domoto-Reilly K, Faber K, Fields J, Fong J, Foroud T, Forsberg LK, Gavrilova R, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Heuer HW, Hsiung GR, Huey E, Irwin D, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kornak J, Kramer JH, Kremers W, Kukull W, Litvan I, Ljubenkov P, Lungu C, Mackenzie I, Mendez MF, Miller BL, Onyike C, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Shaw L, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wong B, Wszolek Z, Rademakers R, Boeve BF, Rosen HJ, Boxer AL, ARTFL/LEFFTDS consortium, Coppola G. PMID: 31914217; PMCID: PMC7199807.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    43. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21. Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dheel C, Dickerson BC, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fields JA, Fishman A, Fong J, Foroud T, Forsberg LK, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant I, Grossman M, Haley D, Hsiung GY, Huey ED, Irwin DJ, Jones DT, Jones L, Kantarci K, Karydas A, Kaufer DI, Kerwin DR, Knopman DS, Kraft R, Kremers WK, Kukull WA, Litvan I, Lucente D, Lungu C, Mackenzie IR, Maldonado M, Manoochehri M, McGinnis SM, McKinley E, Mendez MF, Miller BL, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin KP, Rascovsky K, Roberson ED, Rogalski E, Sengdy P, Shaw LM, Syrjanen J, Tartaglia MC, Tatton N, Taylor J, Toga A, Trojanowski JQ, Weintraub S, Wang P, Wong B, Wszolek Z, Boxer AL, Boeve BF, Kramer JH, Rosen HJ, ARTFL/LEFFTDS consortium. PMID: 31914230; PMCID: PMC6842665.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    44. Nonlinear Z-score modeling for improved detection of cognitive abnormality. Alzheimers Dement (Amst). 2019 Dec; 11:797-808. Kornak J, Fields J, Kremers W, Farmer S, Heuer HW, Forsberg L, Brushaber D, Rindels A, Dodge H, Weintraub S, Besser L, Appleby B, Bordelon Y, Bove J, Brannelly P, Caso C, Coppola G, Dever R, Dheel C, Dickerson B, Dickinson S, Dominguez S, Domoto-Reilly K, Faber K, Ferrall J, Fishman A, Fong J, Foroud T, Gavrilova R, Gearhart D, Ghazanfari B, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grant IM, Grossman M, Haley D, Hsiao J, Hsiung R, Huey ED, Irwin D, Jones D, Jones L, Kantarci K, Karydas A, Kaufer D, Kerwin D, Knopman D, Kraft R, Kramer J, Kukull W, Lapid M, Litvan I, Ljubenkov P, Lucente D, Lungu C, Mackenzie I, Maldonado M, Manoochehri M, McGinnis S, McKinley E, Mendez M, Miller B, Multani N, Onyike C, Padmanabhan J, Pantelyat A, Pearlman R, Petrucelli L, Potter M, Rademakers R, Ramos EM, Rankin K, Rascovsky K, Roberson ED, Rogalski-Miller E, Sengdy P, Shaw L, Staffaroni AM, Sutherland M, Syrjanen J, Tartaglia C, Tatton N, Taylor J, Toga A, Trojanowski J, Wang P, Wong B, Wszolek Z, Boeve B, Boxer A, Rosen H, ARTFL/LEFFTDS Consortium. PMID: 31872042; PMCID: PMC6911910.
      View in: PubMed   Mentions: 7  
    45. Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency. Front Neurol. 2019; 10:1004. Ljubenkov PA, Miller Z, Mumford P, Zhang J, Allen IE, Mitic L, Staffaroni A, Heuer H, Rojas JC, Cobigo Y, Karydas A, Pearlman R, Miller B, Kramer JH, McGrath MS, Rosen HJ, Boxer AL. PMID: 31620075; PMCID: PMC6759464.
      View in: PubMed   Mentions: 5  
    46. THE MULTIDOMAIN IMPAIRMENT RATING (MIR) SCALE: INITIAL RELIABILITY DATA ON A MULTIDIMENSIONAL SCALE DESIGNED FOR FTLD SPECTRUM DISORDERS. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p707-p708. Forsberg FL, Boeve BB, Boxer BA, Rosen RH, Kornak KJ, Heuer HH, Fields FJ, Brushaber BD, Machulda MM, Sturm SV, Staffaroni SA, Ljubenkov LP, Denver DR, Ong OE, Appleby AB, Bordelon BY, Brannelly BP, Coppola CG, Dickerson DB, Dickinson DS, Kimiko KD, Faber FK, Fong FJ, Foroud FT, Gavrilova GR, Gearhart GD, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grossman GM, Hsiung HG, Huey HE, Irwin ID, Jones JD, Kantarci KK, Karydas KA, Kaufer KD, Kerwin KD, Knopman KD, Kraft KR, Kramer KJ, Kremers KW, Kukull KW, Litvan LI, Lucente LD, Lungu LC, Mackenzie MI, McGinnis MS, Mendez MM, Miller MB, Onyike OC, Pantelyat PA, Pearlman PR, Petrucelli PL, Potter PM, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Roberson RE, Rogalski RE, Shaw SL, Sutherland SM, Syrjanen SJ, Tartaglia TC, Tatton TN, Taylor TJ, Toga TA, Trojanowski TJ, Weintraub WS, Wong WB, Wszolek WZ. .
      View in: Publisher Site   Mentions:
    47. FRONTOTEMPORAL LOBAR DEGENERATION RESEARCH IN NORTH AMERICA: PROGRESS IN THE ARTFL/LEFFTDS CONSORTIA. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p1234-p1235. Heuer HH, Boxer BA, Boeve BB, Rosen RH, Forsberg FL, Brushaber BD, Appleby AB, Bordelon BY, Brannelly BP, Coppola CG, Dickerson DB, Dickinson DS, Kimiko KD, Faber FK, Fields FJ, Fong FJ, Foroud FT, Gavrilova GR, Ghoshal GN, Goldman GJ, Graff-Radford GJ, Graff-Radford GN, Grant GI, Grossman GM, Hsiao HJ, Hsiung HG, Huey HE, Irwin ID, Kantarci KK, Karydas KA, Kaufer KD, Kerwin KD, Knopman KD, Kramer KJ, Kremers KW, Kukull KW, Litvan LI, Ljubenkov LP, Lucente LD, Lungu LC, Mackenzie MI, McGinnis MS, Mendez MM, Miller MB, Onyike OC, Pantelyat PA, Pearlman PR, Petrucelli PL, Rademakers RR, Ramos RE, Rankin RK, Rascovsky RK, Roberson RE, Rogalski RE, Shaw SL, Sutherland SM, Syrjanen SJ, Tartaglia TC, Tatton TN, Taylor TJ, Toga TA, Weintraub WS, Wong WB, Wszolek WZ, Consortia CA. .
      View in: Publisher Site   Mentions:
    48. The Multidomain Impairment Rating (MIR) Scale: Initial Reliability Data on a Multidimensional Scale for FTLD (P5.1-010). Neurology. 2019 Apr 9; 92(15_supplement). Boeve BB, Rosen RH, Boxer BA, Kornak KJ, Heuer HH, Fields FJ, Forsberg FL, Brushaber BD, Machulda MM, Sturm SV, Ljubenkov LP, Dever DR, Syrjanen SJ, Kremers KW. .
      View in: Publisher Site   Mentions:
    49. Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials. Brain. 2019 02 01; 142(2):443-459. Staffaroni AM, Ljubenkov PA, Kornak J, Cobigo Y, Datta S, Marx G, Walters SM, Chiang K, Olney N, Elahi FM, Knopman DS, Dickerson BC, Boeve BF, Gorno-Tempini ML, Spina S, Grinberg LT, Seeley WW, Miller BL, Kramer JH, Boxer AL, Rosen HJ. PMID: 30698757; PMCID: PMC6351779.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    50. Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol. 2018 Oct; 5(10):1250-1263. Ljubenkov PA, Staffaroni AM, Rojas JC, Allen IE, Wang P, Heuer H, Karydas A, Kornak J, Cobigo Y, Seeley WW, Grinberg LT, Spina S, Fagan AM, Jerome G, Knopman D, Boeve BF, Dickerson BC, Kramer J, Miller B, Boxer AL, Rosen HJ. PMID: 30349860; PMCID: PMC6186942.
      View in: PubMed   Mentions: 25     Fields:    
    51. THE NIH-EXAMINER IS SENSITIVE TO COGNITIVE CHANGES IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC FAMILIAL FRONTOTEMPORAL DEMENTIA. Alzheimer's & Dementia. 2018 Jul 1; 14(7):p235. Staffaroni SA, Bajorek BL, Ljubenkov LP, Casaletto CK, Elahi EF, Rascovsky RK, Boeve BB, Boxer BA, Bove BJ, Brushaber BD, Coppola CG, Dheel DC, Dickerson DB, Fields FJ, Fong FJ, Forsberg FL, Gavrilova GR, Gearhart GD, Ghoshal GN, Goldman GJ, Radford RJ, Graff-Radford GN, Grossman GM, Haley HD, Heuer HH, Hsiao HJ, Hsiung HG, Huey HE, Irwin ID, Jones JD, Jones JL, Kantarci KK, Karydas KA, Knopman KD, Kornak KJ, Kremers KW, Kukull KW, Lapid LM, Lucente LD, Mackenzie MI, Manoochehri MM, Miller MB, Potter PM, Rademakers RR, Rankin RK, Sutherland SM, Syrjanen SJ, Taylor TJ, Weintraub WS, Wong WB, Wszolek WZ, Rosen RH, Kramer KJ, Consortium CA. .
      View in: Publisher Site   Mentions:
    52. Peripheral Innate Immune Activation Correlates with Disease Severity in GRN Mutation Carriers (P4.178). Neurology. 2018 Apr 10; 90(15_supplement). Ljubenkov LP, Mumford MP, McGrath MM, Allen AI, Miller MZ, Mitic ML, Karydas KA, Heuer HH, Rojas-Martinez RJ, Wang WP, Zhang ZJ, Staffaroni SA, Cobigo CY, Pearlman PR, Miller MB, Rosen RH, Boxer BA. .
      View in: Publisher Site   Mentions:
    53. A Clinical Guide to Frontotemporal Dementias. Focus (Am Psychiatr Publ). 2016 Oct; 14(4):448-464. Ljubenkov PA, Miller BL. PMID: 31975825; PMCID: PMC6519586.
      View in: PubMed   Mentions: 11  
    54. Dementia. Semin Neurol. 2016 Aug; 36(4):397-404. Ljubenkov PA, Geschwind MD. PMID: 27643909.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    Peter's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    _
    Co-Authors (46)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _